VT
BMY icon

Vise Technologies’s Bristol-Myers Squibb BMY Stock Holding History

Vise Technologies’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.18M Buy
141,913
+69,775
+97% +$4.01M 0.09% 176
2026
Q1 		$3.89M Hold
72,138
– – 0.08% 213
2025
Q4 		$3.89M Buy
72,138
+18,547
+35% +$892K 0.08% 214
2025
Q3 		$2.42M Sell
53,591
-22,861
-30% -$1.07M 0.09% 216
2025
Q2 		$3.54M Buy
+76,452
New +$3.75M 0.15% 157
2024
Q4 		$2.54M Buy
44,870
+11,615
+35% +$649K 0.21% 99
2024
Q3 		$1.72M Sell
33,255
-512
-2% -$24K 0.22% 98
2024
Q2 		$1.4M Sell
33,767
-5,410
-14% -$242K 0.25% 91
2024
Q1 		$2.12M Buy
39,177
+6,066
+18% +$309K 0.42% 57
2023
Q4 		$1.7M Buy
33,111
+6,541
+25% +$343K 0.37% 68
2023
Q3 		$1.54M Buy
26,570
+963
+4% +$59K 0.38% 70
2023
Q2 		$1.64M Sell
25,607
-1,489
-5% -$99.8K 0.4% 58
2023
Q1 		$1.88M Buy
27,096
+5,724
+27% +$404K 0.49% 45
2022
Q4 		$1.54M Buy
21,372
+4,173
+24% +$315K 0.48% 46
2022
Q3 		$1.22M Buy
17,199
+316
+2% +$22.9K 0.46% 44
2022
Q2 		$1.3M Buy
16,883
+7,463
+79% +$568K 0.5% 47
2022
Q1 		$688K Buy
+9,420
New +$632K 0.26% 95

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vise Technologies's BMY Position: Q2 2026 in Review

Vise Technologies increased its Bristol-Myers Squibb (BMY) stake by 97% in Q2 2026, buying an estimated $4.01M and bringing the position to 141,913 shares worth $8.18M. The position accounts for 0.09% of the portfolio, ranked #176.

Vise Technologies first reported a position in BMY in Q1 2022 and has held it in 17 quarters since. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Vise Technologies held 141,913 shares of Bristol-Myers Squibb worth $8.18M as of Q2 2026.
  • Vise Technologies bought 69,775 Bristol-Myers Squibb shares in Q2 2026, an estimated $4.01M.
  • Bristol-Myers Squibb made up 0.09% of Vise Technologies's portfolio in Q2 2026, its #176 holding.
  • Vise Technologies first reported a position in Bristol-Myers Squibb in Q1 2022 and has held it in 17 quarters since.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Vise Technologies's 13F filing for Q2 2026, filed 11 Aug 2026.